- •In this large, nationally representative sample, participants with regular marijuana use at almost all frequencies had increased incidence and severity of overactive bladder.
- •Regular marijuana users had an increased nocturia frequency, while no significant difference in incontinence compared to non-regular users.
- •Currently, marijuana appears to be incompetent for the pharmacological treatment of refractory overactive bladder until more robust evidence becomes available.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Trends and age, period and cohort effects for marijuana use prevalence in the 1984-2015 US National Alcohol Surveys.Addiction. 2018; 113: 473-481
Substance Abuse and Mental Health Services Administration. Results from the 2020 National Survey on Drug Use and Health: Detailed Tables. https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables. Accessed March 24, 2022.
- Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial.JAMA Netw Open. 2022; 5e222106
- Combination Pharmacotherapy for Treatment of Overactive Bladder (luts).Curr Urol Rep. 2019; 20: 33
- American Urological A, Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.J Urol. 2015; 193: 1572-1580
- New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA.Ther Clin Risk Manag. 2013; 9: 161-170
- Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder.Neurourol Urodyn. 2019; 38: 22-30
- A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.Clin Rehabil. 2003; 17: 21-29
- The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17: 636-641
- Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.Mult Scler. 2004; 10: 434-441
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.Mult Scler. 2010; 16: 1349-1359
- The Association Between Tetrahydrocannabinol and Lower Urinary Tract Symptoms Utilizing the National Health and Nutrition Examination Survey.Urology. 2019; 123: 120-125
- Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.Eur Urol. 2006; 50 (discussion 1314-1305): 1306-1314
Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed January 12, 2022.
- Validation of the overactive bladder symptom score.J Urol. 2007; 178 (discussion 547): 543-547
- Association between time since quitting smoking and periodontitis in former smokers in the National Health and Nutrition Examination Surveys (NHANES) 2009 to 2012.J Periodontol. 2019; 90: 16-25
- A new equation to estimate glomerular filtration rate.Ann Intern Med. 2009; 150: 604-612
- Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.Diabetes Care. 2020; 43 (Suppl): S14-S31
- Interaction between trouble sleeping and depression on hypertension in the NHANES 2005-2018.BMC Public Health. 2022; 22: 481
- Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.Circulation. 2009; 120: 1640-1645
- Multiple metal exposures and metabolic syndrome: A cross-sectional analysis of the National Health and Nutrition Examination Survey 2011-2014.Environ Res. 2019; 168: 397-405
- National Health and Nutrition Examination Survey: estimation procedures, 2007-2010.Vital Health Stat. 2013; 2: 1-17
- National Health and Nutrition Examination Survey: sample design, 2007-2010.Vital Health Stat. 2013; 2: 1-23
UCLA: Statistical Consulting Group. Survey Data Analysis with R. https://stats.oarc.ucla.edu/r/seminars/survey-data-analysis-with-r/. Accessed January 18, 2022.
- Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and Periodontitis in Adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012.J Periodontol. 2017; 88: 273-280
- Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder.Br J Pharmacol. 1996; 118: 2053-2058
- The endocannabinoid system - a target for the treatment of LUTS?.Nat Rev Urol. 2016; 13: 463-470
- Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility.Urology. 2011; 77 (-1006 e1015): 1006 e1009
- Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.Br J Pharmacol. 2000; 129: 1707-1715
- Current Understanding of Cannabinoids and Detrusor Overactivity.Current Bladder Dysfunction Reports. 2017; 12: 86-94
- Diuretic effects of cannabinoid agonists in mice.Eur J Pharmacol. 2013; 721: 64-69
- Internalization and recycling of the CB1 cannabinoid receptor.J Neurochem. 1999; 73: 493-501
- Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat.Arch Int Pharmacodyn Ther. 1977; 225: 77-87
- Diuretic effects of cannabinoids.J Pharmacol Exp Ther. 2013; 344: 8-14
- Pituitary-adrenal activation and related responses to delta1-tetrahydrocannabinol.Prog Brain Res. 1973; 39: 323-330
- Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity.Neuroscience. 2009; 159: 1154-1163
- Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.JAMA. 2015; 313: 2474-2483
- Adverse health effects of non-medical cannabis use.Lancet. 2009; 374: 1383-1391
- Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know.Am J Cardiol. 2014; 113: 187-190
- Urological complications of illicit drug use.Nat Rev Urol. 2014; 11: 169-177